AMICUS THERAPEUTICS, INC. (39)
Browse by Contract Category
Contracts
-
Form of Director and Officer Indemnification Agreement
(Filed With SEC on December 28, 2022)
-
Equity Distribution Agreement, dated November 7, 2022, by and between Amicus Therapeutics, Inc. and Goldman Sachs & Co. LLC
(Filed With SEC on November 7, 2022)
-
Employment Agreement, dated August 1, 2022, by and between the Company and Bradley L. Campbell
(Filed With SEC on August 1, 2022)
-
Amendment #3 to the Amicus Therapeutics, Inc. Cash Deferral Plan
(Filed With SEC on November 9, 2021)
-
Notice of Non-Renewal of Lease Agreement dated August 16, 2011 between the Registrant and Cedar Brook 3 Corporate Center, L.P
(Filed With SEC on August 10, 2020)
-
Fifth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated April 6, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the...
(Filed With SEC on February 24, 2022)
-
Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2007 Equity Incentive Plan
(Filed With SEC on February 24, 2022)
-
Third Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 3, 2020 by and between Amicus Therapeutics, Inc. and the Trustees of the...
(Filed With SEC on February 24, 2022)
-
Fourth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 23, 2020 by and between Amicus Therapeutics, Inc. and the Trustees of the...
(Filed With SEC on February 24, 2022)
-
Sixth Amendment to the Amended and Restated Research, Collaboration & License Agreement dated August 1, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the...
(Filed With SEC on February 24, 2022)
-
Seventh Amendment to the Amended and Restated Research, Collaboration & License Agreement dated September 28, 2021 by and between Amicus Therapeutics, Inc. and the Trustees of the...
(Filed With SEC on February 24, 2022)
-
Termination Agreement, dated as of February 23, 2022, by and between ARYA and the Company
(Filed With SEC on February 24, 2022)
-
Employment Agreement, dated February 23, 2022, by and between the Company and John F. Crowley
(Filed With SEC on February 24, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on September 29, 2021)
-
Form of Stock Option Award Agreement under the Amended and Restated 2007 Equity Incentive Plan
(Filed With SEC on March 1, 2021)
-
Form of Board Stock Option Award Agreement under the Amended and Restated 2007 Equity Incentive Plan
(Filed With SEC on March 1, 2021)
-
Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2007 Equity Incentive Plan
(Filed With SEC on March 1, 2021)
-
Form of Board Restricted Stock Unit Award Agreement under the Amended and Restated 2007 Equity Incentive Plan
(Filed With SEC on March 1, 2021)
-
Second Amendment to the Amended and Restated Research, Collaboration & License Agreement dated
(Filed With SEC on May 7, 2020)
-
First Amendment to the Amended and Restated Research, Collaboration & License Agreement dated December 20, 2019 by and between Amicus Therapeutics, Inc. and the Trustees of the...
(Filed With SEC on May 7, 2020)
-
Employment Agreement dated February 18, 2020 between the Registrant and Hung Do
(Filed With SEC on March 2, 2020)
-
Employment Agreement dated February 18, 2020, between the Registrant and Daphne Quimi
(Filed With SEC on March 2, 2020)
-
Employment Agreement dated February 18, 2020, between the Registrant and Jay Barth, M.D
(Filed With SEC on March 2, 2020)
-
Employment Agreement dated February 18, 2020, between the Registrant and Bradley L. Campbell
(Filed With SEC on March 2, 2020)
-
Employment Agreement dated February 18, 2020, between the Registrant and Ellen S. Rosenberg
(Filed With SEC on March 2, 2020)
-
Amendment No. 1 to Employment Agreement dated April 23, 2014 between the Registrant and John F. Crowley
(Filed With SEC on March 2, 2020)
-
Description of the Registrant's securities
(Filed With SEC on March 2, 2020)
-
Amendment #2 to the Amicus Therapeutics, Inc. Cash Deferral Plan
(Filed With SEC on December 19, 2019)
-
Amended and Restated Research, Collaboration & License Agreement, dated May 28, 2019, by and between Amicus Therapeutics, Inc. and the Trustees of the University of Pennsylvania
(Filed With SEC on August 8, 2019)
-
Form of Capped Call Transaction Termination Agreement
(Filed With SEC on August 8, 2019)
-
Form of Exchange Agreement Relating to Company's 3.00% Convertible Senior Notes due 2023
(Filed With SEC on June 19, 2019)
-
Underwriting Agreement, dated May 30, 2019, by and among Amicus Therapeutics, Inc., J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and SVB Leerink LLC
(Filed With SEC on May 31, 2019)
-
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023
(Filed With SEC on May 22, 2019)
-
Form of Call Option Partial Termination Agreement
(Filed With SEC on May 9, 2019)
-
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023
(Filed With SEC on March 13, 2019)
-
Separation Agreement with William D. Baird III dated as of February 8, 2019
(Filed With SEC on February 28, 2019)
-
Research, Collaboration and License Agreement with The Trustees of the University of Pennsylvania dated October 8, 2018
(Filed With SEC on February 28, 2019)
-
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023
(Filed With SEC on February 8, 2019)
-
Form of Exchange Agreements Relating to Company's 3.00% Convertible Senior Notes due 2023
(Filed With SEC on January 24, 2019)